New data on the use of immunotherapy in early stages of non–small cell lung cancer (NSCLC) have sparked a debate on which patients benefit most.
Read more
Home »
New data on the use of immunotherapy in early stages of non–small cell lung cancer (NSCLC) have sparked a debate on which patients benefit most.
Read moreLung carcinomas are the leading cause of cancer-related deaths in the United States and worldwide. Lung squamous cell carcinomas (non-small cell lung cancers that arise
Read moreA comprehensive review by University of North Carolina researchers and colleagues of hundreds of publications, incorporating more than two dozen articles on prevention screening for
Read moreMerck & Co is withdrawing the US indication for pembrolizumab (Keytruda) for metastatic small cell lung cancer (SCLC) in patients with disease progression on or
Read moreBrain tumour: Cancer Research UK on 'different types' in 2017 When you subscribe we will use the information you provide to send you these newsletters.Sometimes
Read moreLung cancer is one of the most serious types of cancer to be diagnosed, as it’s usually difficult to spot until it has spread to
Read moreLung cancer is the second most common cancer in both men and women in the UK, with more than 46,000 people diagnosed each year. But
Read moreWhile the medical community agrees that immune cells inside a tumor leads to improved health outcome, for a subset of colorectal cancer patients, having too
Read moreOne of the most common brain cancers in children, Sonic Hedgehog (SHH) medulloblastoma, also is one of the more survivable for most kids. Unfortunately, for
Read moreThe activation of mTor complex 1 in the cell is central to many vital processes in the body such as cell growth and metabolism. Overactivity
Read more